1 McCarthy M.A fifth of lung cancers detected by low dose CT screening are likely to be indolent，study says[J].BMJ，2013，347：f7456.
2 Hawkins S，Wang H，Liu Y，et al. Predicting Malignant Nodules from Screening CT Scans[J].J Thorac Oncol，2016，11（12）：2120-2128.
3 Hirsch F R，Suda K，Wiens J，et al.New and emerging targeted treatments in advanced non-small-cell lung cancer[J].， 2016，388（10048）：1012-1024.
4 Kurie J M，Shin H J，Lee J S，et al. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium[J].Clin Cancer Res，1996，2（10）：1787-1793.
5 Meert A P，Verdebout J M，Martin B，et al. Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions[J].Eur Respir J，2003，21（4）：611-615.
6 Kim T J，Lee C T，Jheon S H，et al.Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations[J].Ann Thorac Surg，2016，101（2）：473-480.
7 Viola P， Maurya M， Croud J，et al.A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer[J].JThorac Oncol， 2016，11（7）：1029-1039.
8 Kumarakulasinghe N B1，van Zanwijk N，Soo RA. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer （NSCLC） [J].Respirology，2015，20（3）：370-378.
9 Drilon A，Cappuzzo F，Ou S H I，et al.Targeting MET in Lung Cancer： Will Expectations Finally Be MET[J]?Journal of Thoracic Oncology，2017，12（1）：15-26.
10 Tammela T，Sanchez-Rivera F J，Cetinbas N M，et al.A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma[J].Nature，Published online 10 May 2017，doi：10.1038/nature22334.
11 Wieland E，Rodriguez-Vita J，Liebler S S，et al.Endothelial Notch1 Activity Facilitates Metastasis[J].Cancer Cell，2017，31（3），1–13.
12 Pannuti A，Foreman K，Rizzo P，et al. Targeting Notch to target cancer stem cells[J]. ClinCancer Res，2010，16（12）：3141-3152.
13 Mack U，Ukena D，Montenarh M，et al.Serum anti-p53 antibodies in patients with lung cancer[J].Oncol Rep，2000，7（3）：669-674.
14 Ren S X，Zhang S C，Jiang T，et al.Early detection of lung cancer by using an autoantibody panel in Chinese population[J]. OncoImmunology. https：//doi.org/10.1080/2162402X.2017.1384108.
15 Yap T A，Lorente D，Omlin A，et al.Circulating Tumor Cells： A Multifunctional Biomarker[J].Clin Cancer Res，2014，20（10）：2553–2568.
16 Taverna S，Giallombardo M，Gilbazo I，et al.Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients： critical analysis of evidence and potential role in clinical practice[J].Oncotarget，2016，7（19）：28748-28760.
17 Vincent F，Naves T，Wilson CM，et al.Sortilin mediates the release and transfer of exosomes in human lung cancer A549 cells[J]. Revue Des Maladies Respiratoires，2015， 32（3）：324-324.
18 Ruiz-Martinez M，Navarro A，Marrades RM，et al.YKT6 expression，exosome release，and survival in non-small cell lung cancer[J]. 2016，7（32）：51515-51524.
19 Qin X，Xu H，Gong W，et al.The Tumor Cytosol miRNAs，Fluid miRNAs，and Exosome miRNAs in Lung Cancer[J]. Front Oncol，2015，5（4）：357.
20 Memczak S，Papavasileiou P，Peters O，et al. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood[J].Plos One，2015，10（10）：e0141214. |
